o2h-ventures

A unique systems pharmacology platform powered by AI to accelerate drug discovery. Uses disruptive AI technology to accelerate the entire drug discovery process by identifying promising candidates, de-risking the opportunities through preclinical validations, and progressing drug candidates to the clinic through industry and investor partnerships

Dexamethasone identified by AI VIVO as high potential for treatment of COVID-19 ten weeks ago
Status Active
Website http://www.aivivo.co/
Category AI
Modality Digital
Therapautics Area Anti-infectives
Headquaters Cambridge, UK
Investment Portfolio Fund Investment
Co-Investors Business Angels, Undisclosed USA Fund